pharma · Epilepsy
Ucb Pharma S.P.A
UCB Pharma
UCB Pharma is a pharma organization headquartered in ANDERLECHT, CN. Primary therapeutic focus areas include Epilepsy. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity
ANDERLECHT, IT HQ
4 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- ANDERLECHT, IT
- Employees
- 4
- Programs
- 2
- Drugs
- 3
- Patents
- 0
Levetiracetam
Phase 3 · small molecule · Epilepsy
Levetiracetam for Epilepsy is a Phase 3 program (small_molecule) at UCB Pharma with 1 ClinicalTrials.gov record(s).
Internal code N01361
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- UCB Pharma
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Epilepsy
- Status
- completed
- Trials
- 1